Share this page
www.indivumed.com/approach/unique-database/
Two surgeons in blue scrubs and masks perform surgery under bright operating lights in a sterile hospital environment.

Data quality is decided in the surgery room.

Tumor tissue starts changing the moment it loses its blood supply. That is why we standardized our collection: median <12 minutes, on every sample, at every site, since 2002.

Unique Database There was no data that matched our ambitions. So, we created our own.

An in-depth multi-omics analysis of matched tumor and normal tissue, combined with comprehensive clinical data, is the foundation of Indivumed’s R&D programs.

Collected and processed in a standardized way in global clinical collaboration over decades, we can now draw on our proprietary database IndivuType® that reflects the molecular reality of cancer at a level never seen before. This is the key to our cutting-edge data analytics for innovative target and drug discovery.

Twelve minutes make all the difference.

It takes years for novel drugs to reach the market, however, the first twelve minutes in the collection, processing, and conservation process are crucial. Research shows that minimizing ischemia time has a major impact on the integrity of tissue samples and is very important to preserve the expression of otherwise undetectable therapeutic targets.

Cancer is an incredibly complex disease – no single layer of data is enough to fully understand it.

In-depth data that reflects the biological reality of cancer

A dataset that captures molecular depth, clinical context, and pathological detail. All from the same patient, across indications and collection sites worldwide.

Clinical data

  • Up to 320 data points per patient
  • Up to ten years of follow-up data

Multi-omics processing

On both tumor and normal tissue

  • Whole genomics
  • Whole transcriptomics
  • Small RNAs
  • Total proteomics
  • Phosphoproteomics
  • More depending on the project

Digital pathology

  • H&E stain scans
  • FFPE sections for IHC

Diverse cancer types

  • CRC, NSCLC, Breast Cancer, and others
  • Samples collected globally (Asia, Europe, Americas)

Comprehensive data

“An incomplete picture of cancer biology leads researchers to overlook potentially important targets or waste time and money on false leads.”

Dr. Silvia von der Heyde | Senior Data Scientist

Tissue collection SOPs Special surgery procedures to protect sample integrity

While surgeons focus on removing the tumor and pathologists on subsequent tissue diagnostics, there is routinely no attention to the conservation of patient material that could be used for further biomedical research.
Together with specialists in our global clinical network, we have developed a series of special standard operating procedures (SOPs) for the collection and preservation of tissue samples. These procedures ensure pre-analytically controlled specimens with a very high sample integrity.

Our clinical network provides us with access to high-quality samples and data.